Ropes & Gray Represents Sanofi in Investment in Atalanta Therapeutics' $97 Million Series B Financing
February 01, 2025
February 01, 2025
BOSTON, Massachusetts, Feb. 1 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray represented Sanofi in its role as co-lead investor in Atalanta Therapeutics' $97 million Series B financing.
Atalanta is a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases.
The financing was co-led by EQT Life Sciences and Sanofi Ventures, with participation from other new investors RiverVest Ventur . . .
Ropes & Gray represented Sanofi in its role as co-lead investor in Atalanta Therapeutics' $97 million Series B financing.
Atalanta is a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases.
The financing was co-led by EQT Life Sciences and Sanofi Ventures, with participation from other new investors RiverVest Ventur . . .